List of Tables
Table 1. Global Tumour-cell Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of MVax
Table 3. Major Manufacturers of OncoVAX
Table 4. Major Manufacturers of BiovaxID
Table 5. Major Manufacturers of Others
Table 6. Global Tumour-cell Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Tumour-cell Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Tumour-cell Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Tumour-cell Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Tumour-cell Vaccine Revenue Market Share by Region (2019-2024)
Table 11. Global Tumour-cell Vaccine Revenue Market Share by Region (2025-2030)
Table 12. Global Tumour-cell Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Tumour-cell Vaccine Sales by Region (2019-2024) & (K Dose)
Table 14. Global Tumour-cell Vaccine Sales by Region (2025-2030) & (K Dose)
Table 15. Global Tumour-cell Vaccine Sales Market Share by Region (2019-2024)
Table 16. Global Tumour-cell Vaccine Sales Market Share by Region (2025-2030)
Table 17. Global Tumour-cell Vaccine Sales by Manufacturers (2019-2024) & (K Dose)
Table 18. Global Tumour-cell Vaccine Sales Share by Manufacturers (2019-2024)
Table 19. Global Tumour-cell Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Tumour-cell Vaccine Revenue Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Tumour-cell Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 22. Tumour-cell Vaccine Price by Manufacturers 2019-2024 (US$/Dose)
Table 23. Global Tumour-cell Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Tumour-cell Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumour-cell Vaccine as of 2023)
Table 25. Global Key Manufacturers of Tumour-cell Vaccine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Tumour-cell Vaccine, Product Offered and Application
Table 27. Global Key Manufacturers of Tumour-cell Vaccine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Tumour-cell Vaccine Sales by Type (2019-2024) & (K Dose)
Table 30. Global Tumour-cell Vaccine Sales by Type (2025-2030) & (K Dose)
Table 31. Global Tumour-cell Vaccine Sales Share by Type (2019-2024)
Table 32. Global Tumour-cell Vaccine Sales Share by Type (2025-2030)
Table 33. Global Tumour-cell Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Tumour-cell Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Tumour-cell Vaccine Revenue Share by Type (2019-2024)
Table 36. Global Tumour-cell Vaccine Revenue Share by Type (2025-2030)
Table 37. Tumour-cell Vaccine Price by Type (2019-2024) & (US$/Dose)
Table 38. Global Tumour-cell Vaccine Price Forecast by Type (2025-2030) & (US$/Dose)
Table 39. Global Tumour-cell Vaccine Sales by Application (2019-2024) & (K Dose)
Table 40. Global Tumour-cell Vaccine Sales by Application (2025-2030) & (K Dose)
Table 41. Global Tumour-cell Vaccine Sales Share by Application (2019-2024)
Table 42. Global Tumour-cell Vaccine Sales Share by Application (2025-2030)
Table 43. Global Tumour-cell Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Tumour-cell Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Tumour-cell Vaccine Revenue Share by Application (2019-2024)
Table 46. Global Tumour-cell Vaccine Revenue Share by Application (2025-2030)
Table 47. Tumour-cell Vaccine Price by Application (2019-2024) & (US$/Dose)
Table 48. Global Tumour-cell Vaccine Price Forecast by Application (2025-2030) & (US$/Dose)
Table 49. US & Canada Tumour-cell Vaccine Sales by Type (2019-2024) & (K Dose)
Table 50. US & Canada Tumour-cell Vaccine Sales by Type (2025-2030) & (K Dose)
Table 51. US & Canada Tumour-cell Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Tumour-cell Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Tumour-cell Vaccine Sales by Application (2019-2024) & (K Dose)
Table 54. US & Canada Tumour-cell Vaccine Sales by Application (2025-2030) & (K Dose)
Table 55. US & Canada Tumour-cell Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Tumour-cell Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Tumour-cell Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Tumour-cell Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Tumour-cell Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Tumour-cell Vaccine Sales by Country (2019-2024) & (K Dose)
Table 61. US & Canada Tumour-cell Vaccine Sales by Country (2025-2030) & (K Dose)
Table 62. Europe Tumour-cell Vaccine Sales by Type (2019-2024) & (K Dose)
Table 63. Europe Tumour-cell Vaccine Sales by Type (2025-2030) & (K Dose)
Table 64. Europe Tumour-cell Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Tumour-cell Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Tumour-cell Vaccine Sales by Application (2019-2024) & (K Dose)
Table 67. Europe Tumour-cell Vaccine Sales by Application (2025-2030) & (K Dose)
Table 68. Europe Tumour-cell Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Tumour-cell Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Tumour-cell Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Tumour-cell Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Tumour-cell Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Tumour-cell Vaccine Sales by Country (2019-2024) & (K Dose)
Table 74. Europe Tumour-cell Vaccine Sales by Country (2025-2030) & (K Dose)
Table 75. China Tumour-cell Vaccine Sales by Type (2019-2024) & (K Dose)
Table 76. China Tumour-cell Vaccine Sales by Type (2025-2030) & (K Dose)
Table 77. China Tumour-cell Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Tumour-cell Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Tumour-cell Vaccine Sales by Application (2019-2024) & (K Dose)
Table 80. China Tumour-cell Vaccine Sales by Application (2025-2030) & (K Dose)
Table 81. China Tumour-cell Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Tumour-cell Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Tumour-cell Vaccine Sales by Type (2019-2024) & (K Dose)
Table 84. Asia Tumour-cell Vaccine Sales by Type (2025-2030) & (K Dose)
Table 85. Asia Tumour-cell Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Tumour-cell Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Tumour-cell Vaccine Sales by Application (2019-2024) & (K Dose)
Table 88. Asia Tumour-cell Vaccine Sales by Application (2025-2030) & (K Dose)
Table 89. Asia Tumour-cell Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Tumour-cell Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Tumour-cell Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Tumour-cell Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Tumour-cell Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Tumour-cell Vaccine Sales by Region (2019-2024) & (K Dose)
Table 95. Asia Tumour-cell Vaccine Sales by Region (2025-2030) & (K Dose)
Table 96. Middle East, Africa and Latin America Tumour-cell Vaccine Sales by Type (2019-2024) & (K Dose)
Table 97. Middle East, Africa and Latin America Tumour-cell Vaccine Sales by Type (2025-2030) & (K Dose)
Table 98. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Tumour-cell Vaccine Sales by Application (2019-2024) & (K Dose)
Table 101. Middle East, Africa and Latin America Tumour-cell Vaccine Sales by Application (2025-2030) & (K Dose)
Table 102. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Tumour-cell Vaccine Sales by Country (2019-2024) & (K Dose)
Table 108. Middle East, Africa and Latin America Tumour-cell Vaccine Sales by Country (2025-2030) & (K Dose)
Table 109. AVAX Technologies Company Information
Table 110. AVAX Technologies Description and Major Businesses
Table 111. AVAX Technologies Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 112. AVAX Technologies Tumour-cell Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. AVAX Technologies Recent Developments
Table 114. Vaccinogen Company Information
Table 115. Vaccinogen Description and Major Businesses
Table 116. Vaccinogen Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 117. Vaccinogen Tumour-cell Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Vaccinogen Recent Developments
Table 119. Biovest Company Information
Table 120. Biovest Description and Major Businesses
Table 121. Biovest Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 122. Biovest Tumour-cell Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Biovest Recent Developments
Table 124. Aduro BioTech Company Information
Table 125. Aduro BioTech Description and Major Businesses
Table 126. Aduro BioTech Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 127. Aduro BioTech Tumour-cell Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Aduro BioTech Recent Developments
Table 129. Regeneus Company Information
Table 130. Regeneus Description and Major Businesses
Table 131. Regeneus Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 132. Regeneus Tumour-cell Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Regeneus Recent Developments
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Tumour-cell Vaccine Distributors List
Table 137. Tumour-cell Vaccine Customers List
Table 138. Tumour-cell Vaccine Market Trends
Table 139. Tumour-cell Vaccine Market Drivers
Table 140. Tumour-cell Vaccine Market Challenges
Table 141. Tumour-cell Vaccine Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumour-cell Vaccine Product Picture
Figure 2. Global Tumour-cell Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Tumour-cell Vaccine Market Share by Type in 2023 & 2030
Figure 4. MVax Product Picture
Figure 5. OncoVAX Product Picture
Figure 6. BiovaxID Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tumour-cell Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Tumour-cell Vaccine Market Share by Application in 2023 & 2030
Figure 10. Pediatrics
Figure 11. Adults
Figure 12. Tumour-cell Vaccine Report Years Considered
Figure 13. Global Tumour-cell Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Tumour-cell Vaccine Revenue 2019-2030 (US$ Million)
Figure 15. Global Tumour-cell Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Tumour-cell Vaccine Revenue Market Share by Region (2019-2030)
Figure 17. Global Tumour-cell Vaccine Sales 2019-2030 ((K Dose)
Figure 18. Global Tumour-cell Vaccine Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Tumour-cell Vaccine Sales YoY (2019-2030) & (K Dose)
Figure 20. US & Canada Tumour-cell Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Tumour-cell Vaccine Sales YoY (2019-2030) & (K Dose)
Figure 22. Europe Tumour-cell Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Tumour-cell Vaccine Sales YoY (2019-2030) & (K Dose)
Figure 24. China Tumour-cell Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Tumour-cell Vaccine Sales YoY (2019-2030) & (K Dose)
Figure 26. Asia (excluding China) Tumour-cell Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Tumour-cell Vaccine Sales YoY (2019-2030) & (K Dose)
Figure 28. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Tumour-cell Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Tumour-cell Vaccine in the World: Market Share by Tumour-cell Vaccine Revenue in 2023
Figure 31. Global Tumour-cell Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Tumour-cell Vaccine Sales Market Share by Type (2019-2030)
Figure 33. Global Tumour-cell Vaccine Revenue Market Share by Type (2019-2030)
Figure 34. Global Tumour-cell Vaccine Sales Market Share by Application (2019-2030)
Figure 35. Global Tumour-cell Vaccine Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Tumour-cell Vaccine Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Tumour-cell Vaccine Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Tumour-cell Vaccine Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Tumour-cell Vaccine Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Tumour-cell Vaccine Revenue Share by Country (2019-2030)
Figure 41. US & Canada Tumour-cell Vaccine Sales Share by Country (2019-2030)
Figure 42. U.S. Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Tumour-cell Vaccine Sales Market Share by Type (2019-2030)
Figure 45. Europe Tumour-cell Vaccine Revenue Market Share by Type (2019-2030)
Figure 46. Europe Tumour-cell Vaccine Sales Market Share by Application (2019-2030)
Figure 47. Europe Tumour-cell Vaccine Revenue Market Share by Application (2019-2030)
Figure 48. Europe Tumour-cell Vaccine Revenue Share by Country (2019-2030)
Figure 49. Europe Tumour-cell Vaccine Sales Share by Country (2019-2030)
Figure 50. Germany Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 51. France Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 55. China Tumour-cell Vaccine Sales Market Share by Type (2019-2030)
Figure 56. China Tumour-cell Vaccine Revenue Market Share by Type (2019-2030)
Figure 57. China Tumour-cell Vaccine Sales Market Share by Application (2019-2030)
Figure 58. China Tumour-cell Vaccine Revenue Market Share by Application (2019-2030)
Figure 59. Asia Tumour-cell Vaccine Sales Market Share by Type (2019-2030)
Figure 60. Asia Tumour-cell Vaccine Revenue Market Share by Type (2019-2030)
Figure 61. Asia Tumour-cell Vaccine Sales Market Share by Application (2019-2030)
Figure 62. Asia Tumour-cell Vaccine Revenue Market Share by Application (2019-2030)
Figure 63. Asia Tumour-cell Vaccine Revenue Share by Region (2019-2030)
Figure 64. Asia Tumour-cell Vaccine Sales Share by Region (2019-2030)
Figure 65. Japan Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 69. India Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Tumour-cell Vaccine Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Tumour-cell Vaccine Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Tumour-cell Vaccine Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Tumour-cell Vaccine Sales Share by Country (2019-2030)
Figure 76. Brazil Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Tumour-cell Vaccine Revenue (2019-2030) & (US$ Million)
Figure 81. Tumour-cell Vaccine Value Chain
Figure 82. Tumour-cell Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed